3 Results for "

Divarasib

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "Divarasib" in MCE Product Catalog:

6
6 Cited Publications
Cat. No.: HY-145928
CAS No.: 2417987-45-0
Purity:  99.31%
Synonyms: GDC-6036
Target:  

Ras

Research Areas:  

Cancer

Divarasib (GDC-6036) is an orally active, selective KRAS G12C inhibitor with an IC50 of <0.01 μM. Divarasib covalently binds Cys12 in GDP-bound KRAS G12C, occupies the switch II pocket, blocks GTP binding and SOS-mediated reactivation, and inhibits oncogenic KRAS signaling. Divarasib induces tumor shrinkage and robust tumor growth inhibition in KRAS G12C-positive models and cancer cells. Divarasib can be used for the research of non-small cell lung cancer, colorectal adenocarcinoma, pancreatic ductal adenocarcinoma, and other KRAS G12C-mutated solid tumors .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-145928B
CAS No.: 2762240-36-6
Synonyms: GDC-6036 adipate
Target:  

Ras

Research Areas:  

Cancer

Divarasib (GDC-6036) adipate is an orally active, selective KRASG12C inhibitor with an IC50 of <0.01 μM. Divarasib adipate covalently binds Cys12 in GDP-bound KRASG12C, occupies the switch II pocket, blocks GTP binding and SOS-mediated reactivation, and inhibits oncogenic KRAS signaling. Divarasib adipate induces tumor shrinkage and robust tumor growth inhibition in KRASG12C-positive models and cancer cells. Divarasib adipate can be used for the research of non-small cell lung cancer, colorectal adenocarcinoma, pancreatic ductal adenocarcinoma, and other KRASG12C-mutated solid tumors .
loading...
    loading...
Cat. No.: HY-181570
Research Areas:  

Cancer

KRAS G12C-IN-73 (Page 21) is a KRAS G12C inhibitor, a derivative of Divarasib (HY-145928), which is applicable for cancer research .
loading...
    loading...